Skip to main content
Clinical Trials/TCTR20170912003
TCTR20170912003
Completed
Phase 4

Determination of dosage and effectiveness of propofol and atracurium for rapid sequence induction of anesthesia: A Prospective double-blind controlled study.

The Royal College of Anesthesiologists of Thailand (RCAT)0 sites122 target enrollmentSeptember 12, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Emergency surgery required rapid sequence induction of anesthesia
Sponsor
The Royal College of Anesthesiologists of Thailand (RCAT)
Enrollment
122
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2017
End Date
September 14, 2017
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
The Royal College of Anesthesiologists of Thailand (RCAT)

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients undergoing elective surgery, aged 20\-65 years, and require general anesthesia
  • 2\. ASA physical status I\-II

Exclusion Criteria

  • 1\. Patients required emergency surgery
  • 2\. Unstable vital signs
  • 3\. History of difficult intubation or anticipated difficult intubation
  • 4\. Patients with history of neuromuscular disease
  • 5\. On anticonvulsant medication for more than 1 month
  • 6\. History of asthma or use bronchodilators
  • 7\. History of allergy to medications used in the study
  • 8\. Obesity, BMI \>30

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
To know the dosage of drug(propofol)needed to anaesthetise a patient with head injury coming for surgery with help of a monitor called bilateral BIS ( bispectral index).Health Condition 1: null- Patients with traumatic brain injury coming for surgeryHealth Condition 2: S065- Traumatic subdural hemorrhage
CTRI/2018/05/013682ational Institute of Mental Health And Neurosciences96
Not yet recruiting
Phase 4
Childhood obesity and propofol infusioChildhood obesityAnaesthesiology - Other anaesthesiologyDiet and Nutrition - Obesity
ACTRN12611000451909Auckland City Hospital60
Active, not recruiting
Not Applicable
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 years
EUCTR2011-001292-39-DEInstitut de Recherches Internationales Servier90
Active, not recruiting
Not Applicable
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 years
EUCTR2011-001292-39-HUInstitut de Recherches Internationales Servier90
Active, not recruiting
Phase 1
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 yearsPaediatric dilated cardiomyopathy and symptomatic chronic heart failureMedDRA version: 14.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2011-001292-39-ESab Servier116